|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
Q
V
PT
|
1,028 Small Cap |
1,207.75 (0.84%) |
21.02 | 3.8 | 46.29 | 132.12 |
|
|
| 2 |
Q
V+
PT
|
3,425 Small Cap |
383.75 (2.27%) |
17.97 | 2.26 | 5.74 | 4.42 |
|
|
| 3 |
Q
V+
PT
|
6,366 Small Cap |
698.75 (-0.46%) |
35.96 | 3.2 | 0.00 | 0.00 |
|
|
| 4 |
Q
V
PT
|
54,328 Mid Cap |
25,721.65 (0.61%) |
35.22 | 11.45 | 9.38 | 18.78 |
|
|
| 5 |
Q
V+
PT
|
29,259 Small Cap |
3,690.15 (3.26%) |
82.51 | 18.11 | 32.80 | 16.82 |
|
|
| 6 |
Q
V
PT
|
3,524 Small Cap |
313.60 (-0.35%) |
26.64 | 4.95 | 7.28 | 11.87 |
|
|
| 7 |
Q
V+
PT
|
41,813 Mid Cap |
3,343.80 (-0.09%) |
39.56 | 9.23 | 13.54 | 10.92 |
|
|
| 8 |
Q
V
PT
|
9,928 Small Cap |
637.05 (1.00%) |
89.81 | 4.13 | 10.00 | 11.58 |
|
|
| 9 |
Q
V+
PT
|
16,267 Small Cap |
815.20 (-1.49%) |
23.75 | 2.82 | 7.69 | -8.97 |
|
|
| 10 |
Q
V
PT
|
13,922 Small Cap |
1,159.50 (2.23%) |
25.21 | 4.27 | 9.20 | 6.61 |
|
|
| 11 |
Q
V+
PT
|
66,524 Mid Cap |
5,495.95 (-1.22%) |
30.07 | 4.69 | 5.71 | 10.33 |
|
|
| 12 |
Q
V
PT
|
42,995 Mid Cap |
771.30 (1.07%) |
64.8 | 13.64 | 23.81 | 40.64 |
|
|
| 13 |
Q
V
PT
|
802 Small Cap |
81.49 (1.88%) |
19.9 | 2.32 | 16.60 | 20.73 |
|
|
| 14 |
Q
V+
PT
|
1,23,896 Large Cap |
8,697.55 (0.94%) |
83.78 | 12.55 | -3.49 | 29.94 |
|
|
| 15 |
Q
V
PT
|
4,154 Small Cap |
259.15 (-1.24%) |
39.66 | 4.72 | 10.15 | 32.48 |
|
|
| 16 |
Q
V+
PT
|
40,198 Mid Cap |
790.60 (1.90%) |
105.54 | 8.95 | -13.71 | 0.61 |
|
|
| 17 |
Q
V
PT
|
20,541 Small Cap |
8,235.90 (0.24%) |
109.8 | 23.59 | 15.59 | 20.47 |
|
|
| 18 |
Q
V+
PT
|
89,345 Mid Cap |
1,560.05 (0.47%) |
37.17 | 3.95 | -3.95 | -0.50 |
|
|
| 19 |
Q
V
PT
|
1,162 Small Cap |
342.20 (-0.88%) |
54.06 | 2.16 | 5.76 | 2.91 |
|
|
| 20 |
Q
V
PT
|
68,154 Mid Cap |
418.90 (0.17%) |
1835.16 | 2.52 | 2.44 | -9.71 |
|
|
| 21 |
Q
V+
PT
|
5,566 Small Cap |
526.50 (0.31%) |
57.64 | 4.88 | 9.41 | 4.67 |
|
|
| 22 |
Q
V
PT
|
9,523 Small Cap |
568.15 (3.49%) |
39.77 | 7.25 | 0.00 | 0.00 |
|
|
| 23 |
Q
V
PT
|
19,475 Small Cap |
2,547.20 (-0.58%) |
30.19 | 5.4 | 17.55 | 21.52 |
|
|
| 24 |
Q
V
PT
|
1,17,699 Mid Cap |
1,456.25 (-0.05%) |
30.33 | 3.42 | 8.01 | 10.07 |
|
|
| 25 |
Q
V+
PT
|
17,265 Small Cap |
452.05 (0.17%) |
96.49 | 4.42 | 7.51 | -3.15 |
|
|
| 26 |
Q
V
PT
|
13,461 Small Cap |
1,284.25 (-0.19%) |
51.49 | 6.66 | 18.56 | 18.12 |
|
|
| 27 |
Q
V+
PT
|
11,991 Small Cap |
2,009 (2.47%) |
66.47 | 16.47 | 19.49 | 18.67 |
|
|
| 28 |
Q
V+
PT
|
2,755 Small Cap |
188 (7.00%) |
30.25 | 0.44 | 5.82 | -33.01 |
|
|
| 29 |
Q
V
PT
|
1,73,684 Large Cap |
6,674.20 (2.01%) |
69 | 10.57 | 11.65 | 10.50 |
|
|
| 30 |
Q
V
PT
|
2,430 Small Cap |
5,105.95 (1.56%) |
35.2 | 7.13 | 17.68 | 31.54 |
|
|
Pharma - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 298.65 | 8.92% | |
| 119.15 | 7.73% | |
| 188 | 7% | |
| 600.85 | 5.26% | |
| 156.45 | 4.40% |
Pharma - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 133.60 | -5.01% | |
| 59.71 | -4.63% | |
| 39.08 | -4.59% | |
| 642.40 | -4.38% | |
| 385.40 | -2.24% |
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | 3B Blackbio Dx Ltd. | 1,028 Crore |
| 2 | Aarti Drugs Ltd. | 3,425 Crore |
| 3 | Aarti Pharmalabs Ltd. | 6,366 Crore |
| 4 | Abbott India Ltd. | 54,328 Crore |
| 5 | Acutaas Chemicals Ltd. | 29,259 Crore |
| 6 | Advanced Enzyme Technologies Ltd. | 3,524 Crore |
| 7 | Ajanta Pharma Ltd. | 41,813 Crore |
| 8 | Akums Drugs & Pharmaceuticals Ltd. | 9,928 Crore |
| 9 | Alembic Pharmaceuticals Ltd. | 16,267 Crore |
| 10 | Alivus Life Sciences Ltd. | 13,922 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,328 | 35.00 | 11.38 | 23.88 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,093 | 72.61 | 18.73 | 38.24 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,813 | 39.60 | 9.24 | 26.75 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,399 | 1,09,576 | 20.55 | 4.88 | 11.89 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,10,608 | 21.95 | 4.25 | 13.46 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,525 | 80,692 | 101 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 36,871 | 41.28 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,093 | 39.25 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,560 | 89,345 | 34.75 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,813 | 31.18 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 36,871 | 54.70 | 9.13 | 33.13 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,487 | 1,02,844 | 50.47 | 6.27 | 31.70 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,813 | 39.60 | 9.24 | 26.75 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,11,792 | 26.64 | 2.95 | 14.87 | 13.26 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,093 | 72.61 | 18.73 | 38.24 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,10,608 | 21.95 | 4.25 | 13.46 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,872 | 4,47,704 | 39.00 | 5.36 | 22.34 | 23.50 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,11,792 | 26.64 | 2.95 | 14.87 | 22.29 |
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,328 | 35.00 | 11.38 | 23.88 | 18.78 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,195 | 60,890 | 44.71 | 5.79 | 11.86 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: